Skip to main navigation
Liquidia Logo
Skip to main content
Liquidia Logo

    Home

  • Home
  • About

  • About Liquidia
    • Overview
    • Leadership
    • Board of Directors
  • Products and Pipeline

  • Pipeline and Products
    • Pipeline
    • Commercial Products
    • PRINT® Technology
    • Publications
  • IR Nav

  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Analyst Coverage
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Corporate Governance
      • Documents & Charters
      • Leadership
      • Board of Directors
      • Committee Composition
    • SEC Filings
    • IR Resources
      • Investor FAQs
      • IR Contact
      • Email Alerts
      • Proxy Online
  • Careers

  • Careers
    • Overview
    • Jobs
    • Benefits
    • Principles
  • Contact Us

  • Contact Us
    • Overview
    • Map/Directions

Events & Presentations

IR Nav

Investors
  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
    Analyst Coverage Stock Quote & Chart Historical Price Lookup Investment Calculator
  • Corporate Governance
    Documents & Charters Leadership Board of Directors Committee Composition
  • SEC Filings
  • IR Resources
    Investor FAQs IR Contact Email Alerts Proxy Online

Events & Presentations

Upcoming Events
More events are coming soon.
Past Events
Liquidia Full Year 2022 Financial Results and Corporate Update Call
Mar 16, 2023 at 8:30 AM EDT
Click here for webcast
Liquidia Third Quarter 2022 Financial Results and Corporate Update Call
Nov 8, 2022 at 8:30 AM EST
Click here for webcast
CHEST 2022 Annual Meeting
Oct 18, 2022 at 2:30 PM EDT
Corporate Update on Hatch-Waxman Litigation
Sep 1, 2022 at 8:00 AM EDT
Click here for webcast
Liquidia Second Quarter 2022 Financial Results and Corporate Update Call
Aug 11, 2022 at 8:30 AM EDT
Click here for webcast
Jefferies Healthcare Conference 2022
Jun 9, 2022 at 8:00 AM EDT
Click here for webcast
Liquidia First Quarter 2022 Financial Results and Corporate Update Call
May 12, 2022 at 8:30 AM EDT
Click here for webcast
Jefferies London Healthcare Conference (Virtual)
Nov 18, 2021 at 8:00 AM GMT
Click here for webcast
Liquidia Investor Conference Call to Discuss Regulatory Update
Nov 8, 2021 at 9:00 AM EST
Click here for webcast
H.C. Wainwright 23rd Annual Global Investment Conference
Sep 13, 2021 at 7:00 AM EDT
Click here for webcast
Jefferies Virtual Healthcare Conference
Jun 2, 2021 at 2:30 PM EDT
Click here for webcast
20th Annual Needham Virtual Healthcare Conference
Apr 14, 2021 from 1:30 PM to 2:10 PM EDT
Click here for webcast

IR Tools

  • Print Page
  • Share
  • RSS
Liquidia Logo

419 Davis Drive, Suite 100, Morrisville, NC 27560
Tel +1 919-328-4400
Fax +1 919-328-4402

Socials

© 2023 Liquidia Corporation All Rights Reserved.

Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology. The company operates through its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH). Liquidia PAH provides the commercialization for rare disease pharmaceutical products, such as generic Treprostinil Injection.

Legal Nav

  • Legal
  • Privacy
  • Cookies
  • Social Media
  • Facebook
  • Twitter
  • LinkedIn